{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T13:21:51Z","timestamp":1776259311136,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1245\/s10434-026-19243-7","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T14:27:52Z","timestamp":1771252072000},"page":"4544-4554","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Utility of Oncotype DX Testing in Synchronous Bilateral and Unilateral Multifocal Breast Cancer"],"prefix":"10.1245","volume":"33","author":[{"given":"Ho Hyun","family":"Ryu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae Kyung","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jisun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Il Yong","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beom Seok","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee Jeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung Ho","family":"Son","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3370-6937","authenticated-orcid":false,"given":"Sae Byul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"19243_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4137\/BCBCR.S13727","volume":"8","author":"M Toole","year":"2014","unstructured":"Toole M. Oncotype DX results in multiple primary breast cancers: Clinical implications on chemotherapy treatment decisions. Breast Cancer (Auckl). 2014;8:1\u20136.","journal-title":"Breast Cancer (Auckl)."},{"key":"19243_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10549-023-07119-3","volume":"203","author":"J Wang","year":"2024","unstructured":"Wang J. Discordance of oncotype DX scores in synchronous bilateral and unilateral multifocal breast cancers. Breast Cancer Res Treat. 2024;203:73\u201383.","journal-title":"Breast Cancer Res Treat."},{"issue":"25","key":"19243_CR3","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1056\/NEJMoa2108873","volume":"385","author":"K Kalinsky","year":"2021","unstructured":"Kalinsky K. 21-Gene assay to inform chemotherapy benefit in node-positive breast cancer. N Engl J Med. 2021;385(25):2336\u201347.","journal-title":"N Engl J Med."},{"issue":"2","key":"19243_CR4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1804710","volume":"379","author":"JA Sparano","year":"2018","unstructured":"Sparano JA. Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer. N Engl J Med. 2018;379(2):111\u201321.","journal-title":"N Engl J Med."},{"key":"19243_CR5","first-page":"5877","volume":"28","author":"J Bloom","year":"2021","unstructured":"Bloom J. Discordance in oncotype DX recurrence scores between synchronous bilateral breast cancers. Ann Surg Oncol. 2021;28:5877\u201385.","journal-title":"Ann Surg Oncol."},{"key":"19243_CR6","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1245\/s10434-015-4841-4","volume":"23","author":"MM Karsten","year":"2016","unstructured":"Karsten MM. Oncotype DX testing in bilateral synchronous primary invasive breast cancer. Ann Surg Oncol. 2016;23:1104\u201310.","journal-title":"Ann Surg Oncol."},{"key":"19243_CR7","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1245\/s10434-018-6866-y","volume":"26","author":"A Grabenstetter","year":"2019","unstructured":"Grabenstetter A. Multifocal ipsilateral carcinomas with similar histology: are multiple oncotype DX tests needed? Ann Surg Oncol. 2019;26:362\u20138.","journal-title":"Ann Surg Oncol."},{"issue":"7","key":"19243_CR8","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nm.3886","volume":"21","author":"LR Yates","year":"2015","unstructured":"Yates LR, Gerstung M, Knappskog S, et al. Subclonal diversification of primary breast cancer revealed by multiregion sequencing. Nat Medicine. 2015;21(7):751\u20139.","journal-title":"Nat Medicine."},{"issue":"5","key":"19243_CR9","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nrc3261","volume":"12","author":"A Marusyk","year":"2012","unstructured":"Marusyk A, Almendro V, Polyak K. Intra-tumour heterogeneity: a looking glass for cancer? Nat Rev Cancer. 2012;12(5):323\u201334.","journal-title":"Nat Rev Cancer."},{"issue":"4","key":"19243_CR10","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/sj.bjc.6602021","volume":"91","author":"MR Teixeira","year":"2004","unstructured":"Teixeira MR, Ribeiro FR, Torres L, et al. Assessment of clonal relationships in ipsilateral and bilateral multiple breast carcinomas by comparative genomic hybridisation and hierarchical clustering analysis. Br J Cancer. 2004;91(4):775\u201382.","journal-title":"Br J Cancer."},{"issue":"27","key":"19243_CR11","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1056\/NEJMoa041588","volume":"351","author":"S Paik","year":"2004","unstructured":"Paik S, Shak S, Tang G, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004;351(27):2817\u201326.","journal-title":"N Engl J Med."},{"issue":"8","key":"19243_CR12","doi-asserted-by":"publisher","first-page":"4256","DOI":"10.1245\/s10434-020-09429-y","volume":"28","author":"KR Pawloski","year":"2021","unstructured":"Pawloski KR, Wen HY, Tadros AB, Abbate K, Morrow M, El-Tamer M. Concordance between 21-gene recurrence scores in multifocal or multicentric breast carcinomas differs by age and histologic subtype. Ann Surg Oncol. 2021;28(8):4256.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"19243_CR13","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1245\/s10434-018-7036-y","volume":"26","author":"DM Euhus","year":"2019","unstructured":"Euhus DM. Selecting the right tumors for genomic testing: DM euhus. Ann Surg Oncol. 2019;26(2):313\u20134.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"19243_CR14","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13058-018-1022-y","volume":"20","author":"J Biermann","year":"2018","unstructured":"Biermann J, Parris TZ, Nemes S, et al. Clonal relatedness in tumour pairs of breast cancer patients. Breast Cancer Res. 2018;20(1):96.","journal-title":"Breast Cancer Res."},{"issue":"4","key":"19243_CR15","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/path.4540","volume":"236","author":"C Desmedt","year":"2015","unstructured":"Desmedt C, Fumagalli D, Pietri E, et al. Uncovering the genomic heterogeneity of multifocal breast cancer. J Pathol. 2015;236(4):457\u201366.","journal-title":"J Pathol."},{"issue":"5","key":"19243_CR16","doi-asserted-by":"publisher","first-page":"331","DOI":"10.6004\/jnccn.2024.0035","volume":"22","author":"WJ Gradishar","year":"2024","unstructured":"Gradishar WJ, Moran MS, Abraham J, et al. Breast cancer, version 3.2024, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2024;22(5):331\u201357.","journal-title":"J Natl Compr Canc Netw."},{"issue":"16","key":"19243_CR17","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1200\/JCO.22.00069","volume":"40","author":"F Andre","year":"2022","unstructured":"Andre F, Ismaila N, Allison KH, et al. Biomarkers for adjuvant endocrine and chemotherapy in early-stage breast cancer: ASCO Guideline Update. J Clin Oncol. 2022;40(16):1816\u201337.","journal-title":"J Clin Oncol."},{"issue":"11","key":"19243_CR18","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1111\/tbj.14288","volume":"27","author":"AD Marumoto","year":"2021","unstructured":"Marumoto AD, Mohan SC, Angarita SAK, et al. Comparison of multiple oncotype DX(\u00ae) from the same patient. Breast J. 2021;27(11):828\u201331.","journal-title":"Breast J."},{"issue":"21","key":"19243_CR19","doi-asserted-by":"publisher","first-page":"5362","DOI":"10.1158\/1078-0432.CCR-15-2889","volume":"22","author":"R Gyanchandani","year":"2016","unstructured":"Gyanchandani R, Lin Y, Lin HM, et al. Intratumor heterogeneity affects gene expression profile test prognostic risk stratification in early breast cancer. Clin Cancer Res. 2016;22(21):5362\u20139.","journal-title":"Clin Cancer Res."},{"issue":"1","key":"19243_CR20","first-page":"1257078","volume":"2017","author":"MG Hanna","year":"2017","unstructured":"Hanna MG, Bleiweiss IJ, Nayak A, Jaffer S. Correlation of Oncotype DX recurrence score with histomorphology and immunohistochemistry in over 500 patients. Int J Breast Cancer. 2017;2017(1):1257078.","journal-title":"Int J Breast Cancer."},{"issue":"2","key":"19243_CR21","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s10549-011-1416-3","volume":"131","author":"K Allison","year":"2012","unstructured":"Allison K, Kandalaft P, Sitlani C, Dintzis S, Gown A. Routine pathologic parameters can predict Onco type DXTM recurrence scores in subsets of ER positive patients: who does not always need testing? Breast Cancer Res Treat. 2012;131(2):413\u201324.","journal-title":"Breast Cancer Res Treat."},{"key":"19243_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.833093","volume":"12","author":"S Li","year":"2022","unstructured":"Li S, Wu J, Huang O, et al. Association of molecular biomarker heterogeneity with treatment pattern and disease outcomes in multifocal or multicentric breast cancer. Front Oncol. 2022;12:833093.","journal-title":"Front Oncol."},{"key":"19243_CR23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.semcdb.2016.08.025","volume":"64","author":"RE Ellsworth","year":"2017","unstructured":"Ellsworth RE, Blackburn HL, Shriver CD, Soon-Shiong P, Ellsworth DL. Molecular heterogeneity in breast cancer: State of the science and implications for patient care. Sem Cell Develop Biol. 2017;64:65\u201372.","journal-title":"Sem Cell Develop Biol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19243-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-19243-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19243-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T12:27:37Z","timestamp":1776256057000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-19243-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["19243"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-19243-7","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"This study was approved by the Institutional Review Board of Asan Medical Center (IRB No. 2022-0282). All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The requirement for informed consent was waived because this study was based on retrospective clinical data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"Generative AI (ChatGPT, OpenAI) was used solely for minor language refinement. No AI tools were involved in study design, data analysis, or interpretation. The authors are fully responsible for all aspects of the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of generative AI in scientific writing"}}]}}